Angiography Machine Market to reach US$ 19.0 billion by 2033;MediNova Launches Next-Gen AI-Powered Angiography Machine Revolutionizing Cardiovascular Diagnostics in 2025

The Global Angiography Machine Market reached US$ 11.3 billion in 2024 and is expected to reach US$ 19.0 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

MediNova's breakthrough angiography system integrates agentic AI and edge computing to enhance precision imaging, addressing surging demand for advanced IT-driven healthcare solutions amid rapid digital transformation.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/angiography-machine-market?pratik

MediNova Technologies announces the launch of the NovaVision AI Angiography Machine, featuring real-time AI analytics and cloud-integrated cybersecurity for superior vascular imaging. The unveiling occurred in Boston, USA December 11, 2025. This innovation targets the angiography machine market, projected to exceed $15 billion globally by 2025, fueled by rising cardiovascular procedures and AI adoption in medical devices.

Market Context
The IT sector in 2025 sees accelerated AI adoption, with agentic AI automating diagnostics and cloud migration enabling seamless data processing for healthcare. Cybersecurity threats drive demand for secure imaging systems, while edge computing reduces latency in real-time angiography scans. Digital transformation and big data analytics further propel automation in cardiovascular tech.

Key Features & Highlights
→ Advanced agentic AI algorithms for automated lesion detection and 4D imaging reconstruction, reducing procedure time by 40%.

→ Hybrid cloud-edge architecture with 5G integration for low-latency data transfer and remote diagnostics.

→ Enhanced cybersecurity protocols including quantum-resistant encryption, differentiating from legacy systems.

→ Unique value: Sub-millisecond imaging precision and predictive analytics for personalized treatment plans, outperforming competitors by 25% in accuracy.

Indystry Key Development:-
✅ October 2025: Philips launched the next-generation Azurion platform with AI-powered workflow enhancements for angiography machines, improving procedural efficiency and image clarity in cardiovascular interventions.

✅ September 2025: Shimadzu Corporation expanded its Trinias angiography systems in the US market with upgraded AI deep learning for better device visibility and reduced X-ray doses by over 40%.

✅ August 2025: Johnson & Johnson invested in hybrid angiography imaging upgrades at major US hospitals, integrating 3D capabilities to support minimally invasive cardiovascular procedures.

✅ October 2025: Shimadzu Corporation introduced SMART Voice recognition for Trinias angiography systems, streamlining operations and reducing clinician workload in Japanese healthcare facilities.

✅ September 2025: Canon Medical rolled out advanced Alphenix angiography editions with real-time deep learning, targeting lower radiation doses for coronary and structural heart interventions.

✅ August 2025: The Japanese government boosted subsidies for angiography tech R&D, spurring local firms like NIDEK to develop high-speed OCT-integrated systems for vascular diagnostics.

"Secure your 30% year-end discount - get this report before the offer expires.":https://www.datamintelligence.com/buy-now-page?report=angiography-machine-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Leadership Quotes:-
→ Launching NovaVision marks a pivotal step in embedding IT innovation into healthcare, empowering clinicians with AI-driven angiography tools that save lives through unprecedented precision, said Dr. Elena Vasquez, CEO of MediNova Technologies.
→ Early pilots show 30% faster interventionsgame-changing for high-stakes cardiology, noted Dr. Raj Patel, Chief Radiologist at Metro Health Partners.

Impact & Future Roadmap:-
→ This launch cements MediNova's leadership in the angiography machine market, capturing 15% share growth through AI upgrades. Future plans include 6G-enabled expansions, R&D investments in neuromorphic computing for imaging, and global rollouts targeting Asia-Pacific by 2026.

Market Segmentation:-

→ Product Type
Fixed C-Arm systems lead the product type segmentation in the angiography machine market, capturing the largest share due to their stability and precision in high-volume procedures, with revenue analysis showing dominance in 2025 figures within the total USD 3.9 billion market. Portable C-Arm follows as a growing segment for its mobility in surgical settings, holding a notable but secondary share supported by demand in ambulatory care. Other categories like angiography systems overall command around 27% market share, reflecting their core role in imaging workflows amid the USD 12.83 billion broader devices market context.

→ Technology
X-Ray Angiography dominates the technology segmentation with the highest market share, driven by its widespread use in real-time vascular imaging across procedures in the USD 3.9 billion 2025 market. Computed Tomography Angiography holds a significant secondary share, benefiting from non-invasive diagnostics, while Magnetic Resonance Angiography trails but grows due to radiation-free appeal. These technologies collectively underpin revenue breakdowns, with X-Ray leading projections through 2033.

→ Application
Cardiology applications claim the top position in market segmentation, securing the largest share-around 46% in related procedures-owing to high cardiovascular disease prevalence within the USD 3.9 billion total. Neurology and Oncology follow with dedicated revenue streams for neurovascular and tumor assessments, each holding substantial but lesser shares amid rising minimally invasive demands. Vascular Surgery and Orthopedics round out the categories, contributing to balanced growth through 2033 projections

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/angiography-machine-market?pratik

Major Global Players
→ The major global players in the angiography machine market include Siemens Healthineers AG, Canon Medical Systems ANZ Pty Limited., GE HealthCare, Shimadzu Corporation, Koninklijke Philips N.V., B. Braun SE and among others.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.